Logo image of BMRC

BANK OF MARIN BANCORP/CA (BMRC) Stock Fundamental Analysis

NASDAQ:BMRC - Nasdaq - US0634251021 - Common Stock - Currency: USD

21.36  +0.63 (+3.04%)

After market: 21.36 0 (0%)

Fundamental Rating

4

Taking everything into account, BMRC scores 4 out of 10 in our fundamental rating. BMRC was compared to 398 industry peers in the Banks industry. The financial health of BMRC is average, but there are quite some concerns on its profitability. BMRC is not valued too expensively and it also shows a decent growth rate. Finally BMRC also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

BMRC had positive earnings in the past year.
BMRC had a positive operating cash flow in the past year.
Of the past 5 years BMRC 4 years were profitable.
In the past 5 years BMRC always reported a positive cash flow from operatings.
BMRC Yearly Net Income VS EBIT VS OCF VS FCFBMRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

BMRC has a worse Return On Assets (-0.23%) than 92.46% of its industry peers.
With a Return On Equity value of -1.93%, BMRC is not doing good in the industry: 92.96% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -0.23%
ROE -1.93%
ROIC N/A
ROA(3y)0.47%
ROA(5y)0.65%
ROE(3y)4.64%
ROE(5y)5.94%
ROIC(3y)N/A
ROIC(5y)N/A
BMRC Yearly ROA, ROE, ROICBMRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

1.3 Margins

BMRC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BMRC Yearly Profit, Operating, Gross MarginsBMRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

4

2. Health

2.1 Basic Checks

BMRC does not have a ROIC to compare to the WACC, probably because it is not profitable.
BMRC has less shares outstanding than it did 1 year ago.
BMRC has more shares outstanding than it did 5 years ago.
BMRC has a better debt/assets ratio than last year.
BMRC Yearly Shares OutstandingBMRC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
BMRC Yearly Total Debt VS Total AssetsBMRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

BMRC has a debt to FCF ratio of 0.01. This is a very positive value and a sign of high solvency as it would only need 0.01 years to pay back of all of its debts.
BMRC's Debt to FCF ratio of 0.01 is amongst the best of the industry. BMRC outperforms 90.45% of its industry peers.
BMRC has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
BMRC's Debt to Equity ratio of 0.00 is amongst the best of the industry. BMRC outperforms 89.20% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z N/A
ROIC/WACCN/A
WACC18.42%
BMRC Yearly LT Debt VS Equity VS FCFBMRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
BMRC Yearly Current Assets VS Current LiabilitesBMRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

5

3. Growth

3.1 Past

BMRC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.89%, which is quite impressive.
BMRC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -18.42% yearly.
The Revenue for BMRC has decreased by -31.97% in the past year. This is quite bad
The Revenue has been decreasing by -6.90% on average over the past years.
EPS 1Y (TTM)22.89%
EPS 3Y-29.7%
EPS 5Y-18.42%
EPS Q2Q%66.67%
Revenue 1Y (TTM)-31.97%
Revenue growth 3Y-13.96%
Revenue growth 5Y-6.9%
Sales Q2Q%22.59%

3.2 Future

The Earnings Per Share is expected to grow by 45.18% on average over the next years. This is a very strong growth
Based on estimates for the next years, BMRC will show a quite strong growth in Revenue. The Revenue will grow by 12.04% on average per year.
EPS Next Y71.62%
EPS Next 2Y45.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year14.46%
Revenue Next 2Y12.04%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BMRC Yearly Revenue VS EstimatesBMRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
BMRC Yearly EPS VS EstimatesBMRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 2

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 20.94, BMRC is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of BMRC indicates a rather expensive valuation: BMRC more expensive than 80.65% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of BMRC to the average of the S&P500 Index (28.22), we can say BMRC is valued slightly cheaper.
BMRC is valuated reasonably with a Price/Forward Earnings ratio of 11.26.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BMRC indicates a slightly more expensive valuation: BMRC is more expensive than 62.06% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of BMRC to the average of the S&P500 Index (20.86), we can say BMRC is valued slightly cheaper.
Industry RankSector Rank
PE 20.94
Fwd PE 11.26
BMRC Price Earnings VS Forward Price EarningsBMRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of BMRC is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 12.43
EV/EBITDA N/A
BMRC Per share dataBMRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BMRC's earnings are expected to grow with 45.18% in the coming years.
PEG (NY)0.29
PEG (5Y)N/A
EPS Next 2Y45.18%
EPS Next 3YN/A

8

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.82%, BMRC is a good candidate for dividend investing.
BMRC's Dividend Yield is rather good when compared to the industry average which is at 3.52. BMRC pays more dividend than 83.42% of the companies in the same industry.
BMRC's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 4.82%

5.2 History

The dividend of BMRC has a limited annual growth rate of 4.66%.
BMRC has been paying a dividend for at least 10 years, so it has a reliable track record.
BMRC has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)4.66%
Div Incr Years18
Div Non Decr Years19
BMRC Yearly Dividends per shareBMRC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

The earnings of BMRC are negative and hence is the payout ratio. BMRC will probably not be able to sustain this dividend level.
BMRC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-192.62%
EPS Next 2Y45.18%
EPS Next 3YN/A
BMRC Yearly Income VS Free CF VS DividendBMRC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

BANK OF MARIN BANCORP/CA

NASDAQ:BMRC (5/2/2025, 8:00:01 PM)

After market: 21.36 0 (0%)

21.36

+0.63 (+3.04%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-28 2025-04-28/bmo
Earnings (Next)07-28 2025-07-28/bmo
Inst Owners59.2%
Inst Owner Change0.12%
Ins Owners8.41%
Ins Owner Change14.32%
Market Cap346.03M
Analysts81.67
Price Target27.13 (27.01%)
Short Float %3.96%
Short Ratio7.21
Dividend
Industry RankSector Rank
Dividend Yield 4.82%
Yearly Dividend1
Dividend Growth(5Y)4.66%
DP-192.62%
Div Incr Years18
Div Non Decr Years19
Ex-Date05-08 2025-05-08 (0.25)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.29%
Min EPS beat(2)3.59%
Max EPS beat(2)14.98%
EPS beat(4)2
Avg EPS beat(4)-20.05%
Min EPS beat(4)-66.42%
Max EPS beat(4)14.98%
EPS beat(8)3
Avg EPS beat(8)-26.73%
EPS beat(12)5
Avg EPS beat(12)-17.51%
EPS beat(16)9
Avg EPS beat(16)-1.6%
Revenue beat(2)0
Avg Revenue beat(2)-5.46%
Min Revenue beat(2)-6.4%
Max Revenue beat(2)-4.52%
Revenue beat(4)0
Avg Revenue beat(4)-6.22%
Min Revenue beat(4)-10.46%
Max Revenue beat(4)-3.52%
Revenue beat(8)0
Avg Revenue beat(8)-5.63%
Revenue beat(12)4
Avg Revenue beat(12)-1.69%
Revenue beat(16)7
Avg Revenue beat(16)0.13%
PT rev (1m)-6.99%
PT rev (3m)-3.62%
EPS NQ rev (1m)0.53%
EPS NQ rev (3m)3.05%
EPS NY rev (1m)-0.42%
EPS NY rev (3m)1.6%
Revenue NQ rev (1m)0.13%
Revenue NQ rev (3m)-0.83%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)0.8%
Valuation
Industry RankSector Rank
PE 20.94
Fwd PE 11.26
P/S 4.72
P/FCF 12.43
P/OCF 12.2
P/B 0.79
P/tB 0.96
EV/EBITDA N/A
EPS(TTM)1.02
EY4.78%
EPS(NY)1.9
Fwd EY8.88%
FCF(TTM)1.72
FCFY8.05%
OCF(TTM)1.75
OCFY8.2%
SpS4.52
BVpS26.88
TBVpS22.21
PEG (NY)0.29
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.23%
ROE -1.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 37.99%
ROA(3y)0.47%
ROA(5y)0.65%
ROE(3y)4.64%
ROE(5y)5.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA N/A
Cap/Depr 21.3%
Cap/Sales 0.71%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC18.42%
ROIC/WACCN/A
Cap/Depr(3y)46.73%
Cap/Depr(5y)41.79%
Cap/Sales(3y)1.32%
Cap/Sales(5y)1.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.89%
EPS 3Y-29.7%
EPS 5Y-18.42%
EPS Q2Q%66.67%
EPS Next Y71.62%
EPS Next 2Y45.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-31.97%
Revenue growth 3Y-13.96%
Revenue growth 5Y-6.9%
Sales Q2Q%22.59%
Revenue Next Year14.46%
Revenue Next 2Y12.04%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-17.89%
FCF growth 3Y-14.28%
FCF growth 5Y-7.17%
OCF growth 1Y-20.45%
OCF growth 3Y-14.42%
OCF growth 5Y-7.07%